Patents by Inventor Jung-Sang Park

Jung-Sang Park has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250114286
    Abstract: The present invention relates to a method for stabilizing ceramide and to a cosmetic composition containing stabilized ceramide and, more specifically, to a method for homogenizing and stabilizing ceramide by self-assembling the ceramide together with ?-sitosterol, resveratrol, and allantoin which are other physiologically active substances using a microfluidic chip and a high pressure homogenizer, and to a technique for using ceramide and nanoparticles containing ?-sitosterol, resveratrol, and allantoin, which are produced by means of the stabilizing method, as a cosmetic material for skin moisturizing, anti-oxidation, skin inflammation relief, skin barrier enhancement, and skin itching relief.
    Type: Application
    Filed: October 10, 2024
    Publication date: April 10, 2025
    Inventors: Hang Eui CHO, Jae Yong SEO, Eun Ji KIM, Hwi Yeob KIM, Ji Soo RYU, Jong Won JEON, Jung Soo KIM, Eun Jeong YOON, Min Ha KIM, Jin Hong KIM, So Hyeon BAE, Si Jun PARK, Hyun Sang LEE
  • Patent number: 12269372
    Abstract: A seat for a vehicle with a cushion tip-up and down function is provided. The seat is configured such that a cushion leg provided in a cushion is held, in a fitted manner, by a support spring of a support structure provided in a seat base, and when the cushion is rotated, the cushion leg is allowed to be folded and ejected by being automatically rotated, thereby improving the convenience of use.
    Type: Grant
    Filed: November 10, 2022
    Date of Patent: April 8, 2025
    Assignees: Hyundai Motor Company, Kia Corporation, Hyundai Transys Inc.
    Inventors: Jung Sang You, Han Su Yoo, Guk Mu Park, Dong Woo Jeong, Myung Hoe Kim, Eun Sue Kim, Dae Hee Lee, Jae Hoon Cho, Han Kyung Park, Jae Sung Shin, Hae Dong Kwak, Gwon Hwa Bok, Jun Sik Hwang
  • Patent number: 12269374
    Abstract: The present disclosure relates to a vehicle rear seat including: a center seat; and side seats located on the left and right of the center seat, wherein, the center seat is capable of protruding by moving the center seat forward with respect to the side seats, and in the state in which the center seat protrudes forward, it is possible to increase an inter-passenger distance so that physical contact between the passenger of the center seat and the passenger of each of the side seats can be prevented as much as possible.
    Type: Grant
    Filed: March 6, 2023
    Date of Patent: April 8, 2025
    Assignees: Hyundai Motor Company, Kia Corporation, Hyundai Transys Inc.
    Inventors: Jung Sang You, Yong Chul Kim, Dae Hee Lee, Eun Sue Kim, Jae Hoon Cho, Han Kyung Park, Jae Sung Shin, Hae Dong Kwak, Jun Sik Hwang, Gwon Hwa Bok
  • Patent number: 12235669
    Abstract: An electronic pedal device includes an accelerator pedal module and a brake pedal module that operate in a pressure operation manner, whereby a driver may operate the same with a small force. The driver may easily recognize the operational state of the pedal based on a haptic signal generated during operation of the pedal. Because operation of the pedal is detected through a dual detecting structure using a Hall sensor and a pressure sensor, safety may be further ensured during operation of the pedal.
    Type: Grant
    Filed: July 10, 2023
    Date of Patent: February 25, 2025
    Assignees: Hyundai Motor Company, Kia Corporation, DONG HEE INDUSTRIAL CO., LTD.
    Inventors: Eun Sik Kim, Wi Sang Park, Jae Hyun Cho, Jung Min Lee, Seong Ju Jo
  • Publication number: 20250062929
    Abstract: A method for performing sidelink groupcast transmission by a transmission terminal includes the steps of: classifying reception terminals belonging to a subject group into two or more subgroups; allocating different groupcast feedback schemes to the two or more subgroups; performing groupcast transmission to the reception terminals; and receiving feedback information from terminals belonging to at least one subgroup among the two or more subgroups according to the different groupcast feedback schemes.
    Type: Application
    Filed: November 5, 2024
    Publication date: February 20, 2025
    Inventors: Jung Hoon LEE, Ju Ho PARK, Jun Hwan LEE, Il Gyu KIM, Jun Hyeong KIM, Go San NOH, Hee Sang CHUNG
  • Publication number: 20230150970
    Abstract: The present invention relates to novel compounds effective as modulators Aryl hydrocarbon receptor (AhR), pharmaceutical composition comprising the compounds for the modulation of AhR, or prevention or treatment of a disease, disorder, or condition associated with AhR activity, as an active ingredient, and thus, can be useful as a medication for the prevention or treatment of a disease, disorder, or condition associated with AhR activity, in particular, cancer, cancerous condition, tumor, fibrotic disease, condition with dysregulated immune responses, etc.
    Type: Application
    Filed: March 29, 2021
    Publication date: May 18, 2023
    Inventors: Jung-Sang PARK, Daewon CHA, Wonhyung LEE, Min Sung JOO, Taeyoung YOON, Hyounmie DOH, Hyun Jung SUNG, Bo Ryeong LEE, Seunghyun SONG, Yoonjung KIM, Ji Hoon CHOI, Hyeon Seok JUNG
  • Publication number: 20230147257
    Abstract: The present invention relates to novel compounds effective as modulators Aryl hydrocarbon receptor (AhR), pharmaceutical composition comprising the compounds for the modulation of AhR, or prevention or treatment of a disease, disorder, or condition associated with AhR activity, as an active ingredient, and thus, can be useful as a medication for the prevention or treatment of a disease, disorder, or condition associated with AhR activity, in particular, cancer, cancerous condition, tumor, fibrotic disease, condition with dysregulated immune responses, etc.
    Type: Application
    Filed: April 19, 2021
    Publication date: May 11, 2023
    Inventors: Minsoo SONG, Ga Young PARK, Jihee KANG, Eunhye LEE, Yoojin PARK, Yujeong CHOI, Soong-Hyun KIM, Eun Bi KO, Seri BAE, Jung-Sang PARK, Daewon CHA, Wonhyung LEE, Min Sung JOO, Taeyoung YOON, Hyounmie DOH, Hyun Jung SUNG, Bo Ryeong LEE, Yoonjung KIM
  • Patent number: 10160724
    Abstract: The present disclosure relates to a novel tetrahydropyridine derivative compound, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof, methods for preparing the compounds, methods for inhibiting UDP-3-O—(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC), methods for treating Gram-negative bacterial infections, the use of the compounds for the preparation of therapeutic medicaments for treating Gram-negative bacterial infections, and pharmaceutical compositions for prevention or treatment of Gram-negative bacterial infections, which contain the compounds. The compounds represented by formula I, stereoisomers thereof or pharmaceutically acceptable salts thereof according to the present disclosure can exhibit excellent effects on the treatment bacterial infections.
    Type: Grant
    Filed: September 28, 2017
    Date of Patent: December 25, 2018
    Assignee: Dong-A St Co., Ltd.
    Inventors: Sun-Ho Choi, Weon-Bin Im, Sung-Hak Choi, Chong-Hwan Cho, Ho-Sang Moon, Jung-Sang Park, Min-Jung Lee, Hyun-Jung Sung, Jun-Hwan Moon, Seung-Hyun Song, Hyung-Keun Lee, Ji-Hoon Choi, Cheon-Hyoung Park, Yoon-Jung Kim, Jin-Hyuk Kim
  • Publication number: 20180086709
    Abstract: The present disclosure relates to a novel tetrahydropyridine derivative compound, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof, methods for preparing the compounds, methods for inhibiting UDP-3-O—(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC), methods for treating Gram-negative bacterial infections, the use of the compounds for the preparation of therapeutic medicaments for treating Gram-negative bacterial infections, and pharmaceutical compositions for prevention or treatment of Gram-negative bacterial infections, which contain the compounds. The compounds represented by formula I, stereoisomers thereof or pharmaceutically acceptable salts thereof according to the present disclosure can exhibit excellent effects on the treatment bacterial infections.
    Type: Application
    Filed: September 28, 2017
    Publication date: March 29, 2018
    Inventors: Sun-Ho Choi, Weon-Bin Im, Sung-Hak Choi, Chong-Hwan Cho, Ho-Sang Moon, Jung-Sang Park, Min-Jung Lee, Hyun-Jung Sung, Jun-Hwan Moon, Seung-Hyun Song, Hyung-Keun Lee, Ji-Hoon Choi, Cheon-Hyoung Park, Yoon-Jung Kim, Jin-Hyuk Kim
  • Patent number: 9828339
    Abstract: Provided are biphenyl derivatives having the structure of Formula 1: stereoisomers thereof, and pharmaceutically acceptable salts thereof, wherein R1 is hydrogen, halogen, hydroxy, substituted or unsubstituted C1-C6 alkyl, or C1-C6 alkoxy; R2, R3 and R4 are each independently hydrogen, halogen, substituted or unsubstituted amino, nitro, cyano, hydroxy, substituted or unsubstituted C1-C6 alkyl, substituted or unsubstituted C1-C6 alkoxy, or —C(O)R6; R5 is hydrogen or C1-C6 alkyl; n is 0 or 1; and R6 is hydrogen or amino, methods for preparing the same, and a pharmaceutical composition containing the same.
    Type: Grant
    Filed: July 17, 2014
    Date of Patent: November 28, 2017
    Assignee: DONG-A ST CO., LTD
    Inventors: Soon-Hoe Kim, Weon-Bin Im, Chong-Hwan Cho, Sun-Ho Choi, Jung-Sang Park, Mi-Yeon Kim, Sung-Hak Choi, Min-Jung Lee, Kang-Hun Cho
  • Patent number: 9676796
    Abstract: The present invention relates to a novel tricyclic benzoxaborole derivative, a preparation method thereof, and use of antibiotics pharmaceutical composition including the same as an active ingredient.
    Type: Grant
    Filed: July 28, 2014
    Date of Patent: June 13, 2017
    Assignee: DONG-A ST CO., LTD.
    Inventors: Soon-Hoe Kim, Weon-Bin Im, Seung-Bum Ha, Jung-Sang Park, Mi-Yeon Kim, Sung-Hak Choi, Hyun-Jung Sung
  • Publication number: 20160176816
    Abstract: The present invention provides novel biphenyl derivatives, isomers thereof, or pharmaceutically acceptable salts thereof, methods for preparing the same, and a pharmaceutical composition containing the same. The novel biphenyl derivatives, isomers thereof, or pharmaceutically acceptable salts thereof, as disclosed in the present invention, act as muscarinic M3 receptor antagonists, and thus are useful for the prevention or treatment of a disease selected from the group consisting of chronic obstructive pulmonary disease, asthma, irritable bowel syndrome, urinary incontinence, rhinitis, spasmodic colitis, chronic cystitis, Alzheimer's disease, senile dementia, glaucoma, schizophrenia, gastroesophageal reflux disease, cardiac arrhythmia, and hyper-salivation syndromes.
    Type: Application
    Filed: July 17, 2014
    Publication date: June 23, 2016
    Inventors: Soon-Hoe KIM, Weon-Bin IM, Chong-Hwan CHO, Sun-Ho CHOI, Jung-Sang PARK, Mi-Yeon KIM, Sung-Hak CHOI, Min-Jung LEE, Kang-Hun CHO
  • Publication number: 20160168167
    Abstract: The present invention relates to a novel tricyclic benzoxaborole derivative, a preparation method thereof, and use of antibiotics pharmaceutical composition including the same as an active ingredient.
    Type: Application
    Filed: July 28, 2014
    Publication date: June 16, 2016
    Applicant: DONG-A ST CO., LTD.
    Inventors: Soon-Hoe Kim, Weon-Bin Im, Seung-Bum Ha, Jung-Sang Park, Mi-Yeon Kim, Sung-Hak Choi, Hyun-Jung Sung
  • Publication number: 20100105727
    Abstract: The present invention provides a novel benzamide derivative represented by formula 1 and an isomer, a pharmaceutically acceptable salt or hydrate thereof, and a composition for activating a 5-HT<sb>4</sb> receptor comprising the same, as an active ingredient. Benzamide derivatives of the present invention has superior affinity for 5-HT<sb>4</sb> receptors, capability to reduce the gastric evacuation time, capability to alleviate ventricular tachycardia, ventricular fibrillation, torsades de pointes and QT prolongation, and low toxicity. Therefore, benzamide derivatives of the present invention are therapeutically effective for digestive system diseases.
    Type: Application
    Filed: March 14, 2008
    Publication date: April 29, 2010
    Applicant: DONG-A-PHARM. CO., LTD.
    Inventors: Moo-Hi Yoo, Jae-Keol Rhee, Weon-Bin Im, Sung-Hak Choi, Eun-Jung Kim, Jung-Sang Park, Sun-Ho Choi, Tae-Kyoung Shon, Hyun-Jung Sung, Ja-Young Kim, Ju-Hee Shon